Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Breast leptomeningeal disease: a review of current practices and updates on management.

Figura NB, Rizk VT, Armaghani AJ, Arrington JA, Etame AB, Han HS, Czerniecki BJ, Forsyth PA, Ahmed KA.

Breast Cancer Res Treat. 2019 Jun 17. doi: 10.1007/s10549-019-05317-6. [Epub ahead of print] Review.

PMID:
31209686
2.

Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.

Figura NB, Rizk VT, Mohammadi H, Evernden B, Mokhtari S, Yu HM, Robinson TJ, Etame AB, Tran ND, Liu J, Washington I, Diaz R, Czerniecki BJ, Soliman H, Han HS, Sahebjam S, Forsyth PA, Ahmed KA.

Breast Cancer Res Treat. 2019 Jun;175(3):781-788. doi: 10.1007/s10549-019-05170-7. Epub 2019 Mar 11.

PMID:
30859348
3.

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.

Eroglu Z, Holmen SL, Chen Q, Khushalani NI, Amaravadi R, Thomas R, Ahmed KA, Tawbi H, Chandra S, Markowitz J, Smalley I, Liu JKC, Chen YA, Najjar YG, Karreth FA, Abate-Daga D, Glitza IC, Sosman JA, Sondak VK, Bosenberg M, Herlyn M, Atkins MB, Kluger H, Margolin K, Forsyth PA, Davies MA, Smalley KSM.

Pigment Cell Melanoma Res. 2019 May;32(3):458-469. doi: 10.1111/pcmr.12771. Epub 2019 Feb 19.

PMID:
30712316
4.

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.

Tawbi HA, Forsyth PA, Algazi A, Hamid O, Hodi FS, Moschos SJ, Khushalani NI, Lewis K, Lao CD, Postow MA, Atkins MB, Ernstoff MS, Reardon DA, Puzanov I, Kudchadkar RR, Thomas RP, Tarhini A, Pavlick AC, Jiang J, Avila A, Demelo S, Margolin K.

N Engl J Med. 2018 Aug 23;379(8):722-730. doi: 10.1056/NEJMoa1805453.

5.

Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.

Beug ST, Beauregard CE, Healy C, Sanda T, St-Jean M, Chabot J, Walker DE, Mohan A, Earl N, Lun X, Senger DL, Robbins SM, Staeheli P, Forsyth PA, Alain T, LaCasse EC, Korneluk RG.

Nat Commun. 2018 Jul 18;9:16231. doi: 10.1038/ncomms16231.

6.

Viral Therapy Gets Personal: A Potential Gene Signature to Predict Susceptibility to Measles Virus Oncolysis.

Forsyth PA, Abate-Daga D.

J Natl Cancer Inst. 2018 Oct 1;110(10):1139-1140. doi: 10.1093/jnci/djy061. No abstract available.

PMID:
29757401
7.

Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.

Sloot S, Chen YA, Zhao X, Weber JL, Benedict JJ, Mulé JJ, Smalley KS, Weber JS, Zager JS, Forsyth PA, Sondak VK, Gibney GT.

Cancer. 2018 May 15;124(10):2254-2255. doi: 10.1002/cncr.31261. Epub 2018 Mar 15. No abstract available.

8.

Oncolytic Virotherapy for Malignant Gliomas.

Forsyth PA, Abate-Daga D.

J Clin Oncol. 2018 May 10;36(14):1440-1442. doi: 10.1200/JCO.2017.77.3192. Epub 2018 Feb 13. No abstract available.

PMID:
29437534
9.

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience.

Figura NB, Long W, Yu M, Robinson TJ, Mokhtari S, Etame AB, Tran ND, Diaz R, Soliman H, Han HS, Sahebjam S, Forsyth PA, Ahmed KA.

Breast Cancer Res Treat. 2018 Jun;169(2):391-396. doi: 10.1007/s10549-018-4684-3. Epub 2018 Feb 1.

PMID:
29392582
10.

The biology and therapeutic management of melanoma brain metastases.

Abate-Daga D, Ramello MC, Smalley I, Forsyth PA, Smalley KSM.

Biochem Pharmacol. 2018 Jul;153:35-45. doi: 10.1016/j.bcp.2017.12.019. Epub 2017 Dec 24. Review.

11.

The Blood Brain Barrier and BRAF inhibitors: Implications for patients with melanoma brain metastases.

Smalley KSM, Forsyth PA.

Pharmacol Res. 2018 Sep;135:265-267. doi: 10.1016/j.phrs.2017.11.013. Epub 2017 Nov 13. No abstract available.

PMID:
29146209
12.

Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.

Sloot S, Chen YA, Zhao X, Weber JL, Benedict JJ, Mulé JJ, Smalley KS, Weber JS, Zager JS, Forsyth PA, Sondak VK, Gibney GT.

Cancer. 2018 Jan 15;124(2):297-305. doi: 10.1002/cncr.30946. Epub 2017 Oct 12.

13.

BRAF-MEK inhibition in melanoma brain metastases: a new hope.

Forsyth PA, Smalley KSM, Sondak VK.

Lancet Oncol. 2017 Jul;18(7):836-837. doi: 10.1016/S1470-2045(17)30449-7. No abstract available.

PMID:
28677560
14.

Erratum to: Older age at the completion of linear growth is associated with an increased risk of adult glioma.

Little RB, Burt Nabors L, Olson JJ, Thompson ZJ, Rozmeski CM, LaRocca RV, Forsyth PA, Thompson RC, Oster RA, Chowdhary SA, Egan KM.

Cancer Causes Control. 2017 Jul;28(7):717-718. doi: 10.1007/s10552-017-0893-z. No abstract available.

PMID:
28455551
15.

Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomy.

Groshev A, Padalia D, Patel S, Garcia-Getting R, Sahebjam S, Forsyth PA, Vrionis FD, Etame AB.

Clin Neurol Neurosurg. 2017 Jun;157:25-30. doi: 10.1016/j.clineuro.2017.03.017. Epub 2017 Mar 20.

PMID:
28384595
16.

Older age at the completion of linear growth is associated with an increased risk of adult glioma.

Little RB, Nabors LB, Olson JJ, Thompson ZJ, Rozmeski CM, LaRocca RV, Forsyth PA, Thompson RC, Oster RA, Chowdhary SA, Egan KM.

Cancer Causes Control. 2017 Jul;28(7):709-716. doi: 10.1007/s10552-017-0871-5. Epub 2017 Mar 4. Erratum in: Cancer Causes Control. 2017 Jul;28(7):717-718.

17.

Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.

Beug ST, Beauregard CE, Healy C, Sanda T, St-Jean M, Chabot J, Walker DE, Mohan A, Earl N, Lun X, Senger DL, Robbins SM, Staeheli P, Forsyth PA, Alain T, LaCasse EC, Korneluk RG.

Nat Commun. 2017 Feb 15;8. doi: 10.1038/ncomms14278. Erratum in: Nat Commun. 2018 Jul 18;9:16231.

18.

Experimental Treatments for Leptomeningeal Metastases From Solid Malignancies.

Sahebjam S, Forsyth PA, Smalley KS, Tran ND.

Cancer Control. 2017 Jan;24(1):42-46. Review.

PMID:
28178711
19.

A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.

Fedorenko IV, Evernden B, Kenchappa RS, Sahebjam S, Ryzhova E, Puskas J, McIntosh L, Caceres G, Magliocco A, Etame A, Harbour JW, Smalley KS, Forsyth PA.

Melanoma Res. 2016 Oct;26(5):481-6. doi: 10.1097/CMR.0000000000000274. Review.

20.

Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.

Smalley KS, Fedorenko IV, Kenchappa RS, Sahebjam S, Forsyth PA.

Int J Cancer. 2016 Sep 15;139(6):1195-201. doi: 10.1002/ijc.30147. Epub 2016 Apr 30. Review.

Supplemental Content

Loading ...
Support Center